The femtech market refers to technology-driven products, software, and services designed to address women’s health needs across areas such as reproductive health, pregnancy and nursing care, menstrual health, sexual wellness, fertility management, and menopause support. It includes mobile health apps, wearable devices, diagnostic tools, digital therapeutics, and connected medical devices tailored to improve women’s well-being and healthcare access. Market growth is fueled by rising awareness of women’s health issues, increasing adoption of digital health technologies, and growing investment in female-focused innovations. The surge in fertility tracking apps, telehealth consultations for gynecological care, and personalized health platforms has significantly expanded the industry’s scope.
The global femtech market size was valued at USD 7.81 billion in 2024 and is projected to grow from USD 9.12 billion in 2025 to USD 28.89 billion by 2032, exhibiting an impressive CAGR of 17.9% during the forecast period. The market’s rapid growth is driven by increasing awareness and adoption of digital health solutions tailored for women’s health, spanning areas such as fertility tracking, pregnancy care, menstrual health, menopause management, and chronic disease monitoring.
North America dominated the femtech market in 2024 with a market share of 53.64%, attributed to its strong digital infrastructure, early technology adoption, and rising focus on women’s wellness and preventive healthcare solutions.